We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Life Science Reit Plc | LSE:LABS | London | Ordinary Share | GB00BP5X4Q29 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.30 | 0.79% | 38.50 | 488,107 | 16:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 38.00 | 38.50 | 38.50 | 38.50 | 38.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Real Estate Investment Trust | 19.94M | -21.71M | -0.0620 | -6.21 | 133.7M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:35:02 | UT | 22,644 | 38.50 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 13/12/2024 | 17:25 | UK RNS | Life Science REIT PLC Holding(s) in Company |
| 28/11/2024 | 14:20 | UK RNS | Life Science REIT PLC Holding(s) in Company |
| 27/11/2024 | 07:00 | UK RNS | Life Science REIT PLC Holding(s) in Company |
| 26/11/2024 | 15:26 | UK RNS | Life Science REIT PLC Holding(s) in Company |
| 25/11/2024 | 16:29 | UK RNS | Life Science REIT PLC Holding(s) in Company |
| 22/11/2024 | 16:38 | UK RNS | Life Science REIT PLC Holding(s) in Company |
| 15/11/2024 | 07:00 | UK RNS | Life Science REIT PLC Purchase of Ordinary Shares by Investment Adviser |
| 13/11/2024 | 16:19 | UK RNS | Life Science REIT PLC Holding(s) in Company |
| 14/10/2024 | 13:19 | ALNC |  IN BRIEF: Life Science REIT completes new lease at Oxford Tech Park |
| 14/10/2024 | 08:34 | UK RNS | Life Science REIT PLC Holding(s) in Company |
Life Science Reit (LABS) Share Charts1 Year Life Science Reit Chart |
|
1 Month Life Science Reit Chart |
Intraday Life Science Reit Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 29/10/2024 | 09:09 | LIFE SCIENCE REIT | 349 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-12-13 16:35:02 | 38.50 | 22,644 | 8,717.94 | UT |
| 2024-12-13 16:29:57 | 38.50 | 5 | 1.93 | O |
| 2024-12-13 16:23:46 | 38.17 | 15,000 | 5,725.22 | O |
| 2024-12-13 15:59:55 | 38.50 | 7,237 | 2,786.25 | O |
| 2024-12-13 15:51:21 | 38.17 | 10,000 | 3,816.84 | O |
| Top Posts |
|---|
Posted at 13/12/2024 08:20 by Life Science Reit Daily Update Life Science Reit Plc is listed in the Real Estate Investment Trust sector of the London Stock Exchange with ticker LABS. The last closing price for Life Science Reit was 38.20p.Life Science Reit currently has 350,000,000 shares in issue. The market capitalisation of Life Science Reit is £134,750,000. Life Science Reit has a price to earnings ratio (PE ratio) of -6.21. This morning LABS shares opened at 38.50p |
Posted at 27/9/2024 10:20 by wshak I'm not sure why LABS was created as a REIT, as it's far too small. Who cares if selling Herbrand St ends its future as a REIT - it's not cost effective anyway.Perhaps they thought that they could issue loads of shares at full NAV, and get bigger that way. Historically, that has been the model for these REITs and ITs whilst they were valued highly.Different model now, though. Investors want their money back, and they won't care if LABS survives as a REIT or not. |
Posted at 26/9/2024 13:49 by hugepants I doubled up this morning. The narrative is quite confident.I was half expecting a huge nav writedown to match the share price fall. |
Posted at 17/9/2024 07:13 by ghhghh LABS told me that they were outbid on Herbrand Street by BL. Aside from the lack of parking it looks a quality, well located asset. I think they paid £90m and last accounts valued it at £80m.About 2 years left on the lease and LABS now appear unable to pursue Plan A (refurb for life sciences) so Plan B screams sell it! |
Posted at 16/9/2024 20:11 by hugepants Still the discount looks extreme? A 60% discount to NAV would imply to me something structural re the debt, like covenants under threat? But LABS claim they have substantial covenant headroom. RGL traded on a similar discount (before the discounted fundraising) but it was a complete basket case! CLS is on a similar discount but it has 50% LTV and is family owned. LABS LTV is currently only 25%. So with reits recovering in price now , albeit slowly, LABS is continuing to fall which feels anomalous. |
Posted at 16/9/2024 15:33 by riverman77 Briefly looked at this a few months ago and was surprised that a large part of their exposure is actually offices, not labs. That was enough to keep me away, thankfully. Looks like some of these could be converted to labs, but the costs would be high. |
Posted at 16/9/2024 15:14 by wshak The 2 dogs in my IT and REIT portfolio are DGI9 and LABS.With DGI9, I averaged down heavily at a blended 21p, but have bought none since the latest NAV "re-valuation". Risks have risen there, given the latest update. LABS is giving me similar vibes, but at least it is property based, which is easier to understand. Shares are very illiquid at the moment, so any kind of serious buying or selling will affect the price disproportionately. If LABS don't start letting out OTP soon, there will be significant pressure on the Board to look for strategic options - ie. put themselves up for sale. One REIT I'd been keeping my eye on (but never bought) was PRSR. A real dog, much like LABS, it has soared purely due to activist investors calling an EGM and getting their men on the Board. LABS is an interesting case. Their debt isn't very high so I'd have thought that management must be very conscious of the share price and existing discount to NAV. The size of the company is such that there will be a whole load of rapacious types who could take a longer term view and look to take them private with an opportunistic bid. LABS have to start delivering soon - by achieving decent rents, not by panic discounting - or they will be toast. |
Posted at 16/9/2024 14:16 by ghhghh They let the first part of OTP reasonably quickly but agree that the market may have changed. Hence their conversion of Unit 4 into smaller IQ units (4 out of 9 let) and they are revisiting the planning on Units 10 and 11 which are due mid 2025.By my very rough calcs, OTP is 498,000 ft fully developed of which Units 10 and 11 total 83,000 sq ft. So currently 425,000 sq ft (but incl hotel) of which 210,000 sq ft is currently/imminently available. Most of this vacant space is fairly recent so possibly too soon to panic in view of summer holidays/GE/forthcom Worst case, the portfolio looks decent quality and well located in the golden triangle, it should have sufficient value to more than cover the current share price. Especially as REIT sentiment is improving with falling interest rates and LABS is now lagging well behind the sector rally. |
Posted at 30/8/2024 08:55 by ghhghh Jefferies's Mike Prew has downgraded LABS to 36p from 45p, citing slow letting progress at OTP due to economic and political uncertainties and limited VC funding.He expects activity to pick up into 2025. No surprises here as per my previous post. LABs have until 26th Sept to finalise a couple of OTP lettings.... July/August always quiet thanks to holidays but hopefully September will see deal activity increasing. However the imminent Budget may keep some on the sidelines. |
Posted at 24/7/2024 06:58 by ghhghh The short term risk is Oxford Technology Park. LABs need to start letting out the speculative new space they are building. Accepted we’ve had an Election and everyone appears to be on holiday at the moment but I will begin to worry if nothing announced by mid August.All LABs have told me is that very busy…. However mid term I think LABs is a stunning buy. OTP is immediately north of Begbroke’s existing Science Park owned by the University. OTP is better located, fronting Oxford Airport. The University are currently seeking planning for: Begbroke Science Park is in the middle of all the fields. OTP is a field away from the proposed Innovation site boundary. Google search…. This is encouraging for two reasons. It illustrates significant future demand and that OTP is well located. |
Posted at 20/5/2024 07:41 by cwa1 Someone mentioned LABS to me the other day, so I thought I must have a look. I've had barely a 5 minute look so far, so barely even scratched the surface...The share price chart looks brilliant, just the way I like it(unless, of course, they are genuinely awful/about to go bust). A lot of the portfolio is in offices. As Graham Taylor once said: Do I NOT like that. I suppose there's an argument that it's "all in the price" already however? Recent dividend cut...errr, sorry, "rebasing". Clearly not good news from an investor point of view but sensible from a business standpoint I feel. However there are loads of chunkier yields out there that remunerate you handsomely whilst you wait for the company to re-rate. So not perfect. There looks to be a willing and commited seller out there. That cuts two ways of course but I'd rather be buying when there selling was coming to an end/drying up. Having said that, it's worth a deeper look as there's a bit to do to understand it. Anyone care to add their tuppence worth? Or even just ring a bell when it's at the bottom? ;-) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
